Geode Capital Management’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.21M Sell
1,193,138
-38,237
-3% -$263K ﹤0.01% 2481
2025
Q1
$3.55M Sell
1,231,375
-63,140
-5% -$182K ﹤0.01% 2828
2024
Q4
$6.09M Sell
1,294,515
-26,347
-2% -$124K ﹤0.01% 2646
2024
Q3
$4.72M Buy
1,320,862
+13,485
+1% +$48.2K ﹤0.01% 2787
2024
Q2
$8.11M Buy
1,307,377
+743,919
+132% +$4.61M ﹤0.01% 2455
2024
Q1
$5.32M Buy
563,458
+10,228
+2% +$96.6K ﹤0.01% 2664
2023
Q4
$3.74M Buy
553,230
+18,727
+4% +$126K ﹤0.01% 2846
2023
Q3
$2.37M Sell
534,503
-31,306
-6% -$139K ﹤0.01% 3017
2023
Q2
$1.87M Sell
565,809
-496,825
-47% -$1.64M ﹤0.01% 3132
2023
Q1
$3.03M Buy
1,062,634
+206,802
+24% +$589K ﹤0.01% 2851
2022
Q4
$6.23M Buy
855,832
+230,762
+37% +$1.68M ﹤0.01% 2538
2022
Q3
$5.06M Buy
625,070
+58,557
+10% +$474K ﹤0.01% 2672
2022
Q2
$2.78M Buy
566,513
+36,376
+7% +$178K ﹤0.01% 3002
2022
Q1
$12.5M Buy
530,137
+32,132
+6% +$760K ﹤0.01% 2194
2021
Q4
$8.81M Buy
498,005
+39,563
+9% +$700K ﹤0.01% 2540
2021
Q3
$12.9M Buy
458,442
+101,850
+29% +$2.87M ﹤0.01% 2274
2021
Q2
$3.74M Buy
356,592
+71,855
+25% +$753K ﹤0.01% 3068
2021
Q1
$3.35M Buy
284,737
+77,067
+37% +$908K ﹤0.01% 2981
2020
Q4
$2.43M Buy
207,670
+59,587
+40% +$698K ﹤0.01% 2976
2020
Q3
$1.17M Buy
148,083
+21,961
+17% +$174K ﹤0.01% 3145
2020
Q2
$2.31M Buy
126,122
+5,720
+5% +$105K ﹤0.01% 2764
2020
Q1
$1.44M Buy
120,402
+61,701
+105% +$736K ﹤0.01% 2849
2019
Q4
$976K Buy
58,701
+30,910
+111% +$514K ﹤0.01% 3285
2019
Q3
$184K Buy
+27,791
New +$184K ﹤0.01% 3801